CVC has finalized a €2.2 billion acquisition of Animal Nutrition & Health from DSM-Firmenich, consolidating its position in the animal health sector. The deal, announced by PE Hub, sees CVC take full ownership of the business unit, while DSM-Firmenich retains a 20 percent equity stake. This transaction underscores CVC's strategic push into life sciences and animal health, a sector experiencing significant consolidation. The purchase price reflects the high value placed on ANH's portfolio of products and technologies. CVC's investment signals confidence in the long-term growth prospects of animal nutrition and health solutions, driven by rising demand for sustainable and efficient livestock farming practices globally.

ANH's integration into CVC's portfolio adds substantial scale and diversification to its existing animal health assets. The retained stake by DSM-Firmenich suggests a continued partnership, potentially involving technology transfer or co-development of products. This move positions CVC as a major player in the animal health market, competing with larger pharmaceutical and agribusiness companies. The financial terms highlight the sector's attractiveness, with CVC committing significant capital to expand its life sciences footprint.

The acquisition has immediate implications for DSM-Firmenich's balance sheet, freeing up capital and resources previously tied to ANH. For CVC, it represents a strategic bet on the resilience and growth potential of animal health amid broader economic uncertainties. The deal also reflects shifting industry dynamics, where specialized companies like ANH are increasingly attractive targets for larger private equity firms seeking niche expertise and market access. CVC's move follows a trend of PE firms entering the animal health space, attracted by innovation and demand for alternative protein and health solutions.

Quick Fact: CVC paid €2.2 billion for Animal Nutrition & Health from DSM-Firmenich.